Can we really beat cervical cancer?

被引：9

作者：

Garland, SM ^{[1
]}

机构：

[1] Royal Womens Hosp, Dept Microbiol & Infect Dis, Carlton, Vic, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2003年 / 178卷 / 12期

关键词：

D O I：

10.5694/j.1326-5377.2003.tb05396.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：647 / 649

页数：3

共 13 条

[1] The causal relation between human papillomavirus and cervical cancer
Bosch, FX
Lorincz, A
Muñoz, N
Meijer, CJLM
Shah, KV
[J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
[2] Ferlay J., 2001, GLOBOCAN 2000 CANC I
[3] *INT AG RES CANC, 1995, MON EV CARC RISKS HU, V64
[4] Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study (vol 325, pg 572, 2002)
Kjaer, S. K.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
[5] A controlled trial of a human papillomavirus type 16 vaccine
Koutsky, LA
Ault, KA
Wheeler, CM
Brown, DR
Barr, E
Alvarez, FB
Chiacchierini, LM
Jansen, KU
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) : 1645 - 1651
[6] Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N
Bosch, FX
de Sanjosé, S
Herrero, R
Castellsagué, X
Shah, KV
Snijders, PJF
Meijer, CJLM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) : 518 - 527
[7] Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis
Sherman, ME
Lorincz, AT
Scott, DR
Wacholder, S
Castle, PE
Glass, AG
Mielzynska-Lohnas, I
Rush, BB
Schiffman, M
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (01): : 46 - 52
[8] Steller Michael A, 2002, Curr Opin Investig Drugs, V3, P37
[9] Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt
[10] 12::AID-PATH431&gt

← 1 2 →